RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanghai Fosun Pharmaceutical Group Co Stock

Shanghai Fosun Pharmaceutical Group Co Employees 2024

Shanghai Fosun Pharmaceutical Group Co Employees

31,370

Ticker

600196.SS

ISIN

CNE000000X38

In 2024, Shanghai Fosun Pharmaceutical Group Co employed 31,370 people, a 0% change from the 31,370 number of employees in the previous year.

Shanghai Fosun Pharmaceutical Group Co Aktienanalyse

What does Shanghai Fosun Pharmaceutical Group Co do?

Shanghai Fosun Pharmaceutical Group Co Ltd is a Chinese company specializing in the healthcare industry. It was founded in 1994 and is headquartered in Shanghai. The company has grown to become one of the largest pharmaceutical conglomerates in China and operates internationally. The company's history began in the 1990s with the establishment of Shanghai Fosun High-Tech (Group) Co. Ltd. Through the acquisition of local pharmaceutical companies, Fosun quickly secured a place among the major players in the Chinese pharmaceutical market. From the beginning, the development, production, and marketing of pharmaceutical products and medical devices were the main focus. Today, Shanghai Fosun Pharmaceutical is a holding company with various subsidiaries operating in different areas of medicine. These include the development of innovative drugs, the production of generic drugs, and the business-to-consumer sector. The company generates an annual revenue of over six billion US dollars. One of Shanghai Fosun Pharmaceutical's most well-known products is the drug Alunbrig for the treatment of lung cancer. It is a tyrosine kinase inhibitor that inhibits the growth of cancer cells. Alunbrig has shown good results in clinical studies and is now approved for the treatment of lung cancer in many countries. Another important business area for Shanghai Fosun Pharmaceutical is the production of generic drugs. These are imitations of already approved, often expensive, original drugs. Fosun manufactures such medications at a significantly lower cost than the original manufacturer, making them more accessible to a broader population. In addition to drug development and generic production, Shanghai Fosun Pharmaceutical is also active in other areas of the healthcare industry. In recent years, the company has acquired several private hospitals in China and operates them under the name Fosun International Hospitals. Special emphasis is placed on state-of-the-art medical technology and patient-oriented care. Another important area is the manufacturing of medical devices. Shanghai Fosun Pharmaceutical works closely with partners from both domestic and foreign markets to develop innovative products. An example is the artificial hip joint, which was developed in collaboration with an American partner company. Fosun produces and distributes over 70 different types of medical devices. In summary, Shanghai Fosun Pharmaceutical Group is an innovative company specializing in various areas of the healthcare industry. Through its consistent focus on growth and innovation, Fosun has steadily expanded in recent years and has become one of the key players in the Chinese pharmaceutical market. However, the global expansion and ambitious goals also leave room for risks and mistakes. Shanghai Fosun Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Shanghai Fosun Pharmaceutical Group Co's Employee Base

Shanghai Fosun Pharmaceutical Group Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Shanghai Fosun Pharmaceutical Group Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing Shanghai Fosun Pharmaceutical Group Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Shanghai Fosun Pharmaceutical Group Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Shanghai Fosun Pharmaceutical Group Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Shanghai Fosun Pharmaceutical Group Co stock

How many employees does Shanghai Fosun Pharmaceutical Group Co have this year?

Shanghai Fosun Pharmaceutical Group Co has 31,370 undefined employees this year.

How many employees did Shanghai Fosun Pharmaceutical Group Co have compared to the previous year?

Compared to the previous year, Shanghai Fosun Pharmaceutical Group Co had 0% more employees.

What impact did the number of employees have on the company Shanghai Fosun Pharmaceutical Group Co?

The number of employees has a direct impact on the efficiency and productivity of Shanghai Fosun Pharmaceutical Group Co. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Shanghai Fosun Pharmaceutical Group Co?

The number of employees can also have an impact on investors of Shanghai Fosun Pharmaceutical Group Co, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Shanghai Fosun Pharmaceutical Group Co affect the company?

An increase in equity of Shanghai Fosun Pharmaceutical Group Co can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Shanghai Fosun Pharmaceutical Group Co's equity affect the company?

A reduction in equity of Shanghai Fosun Pharmaceutical Group Co can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Shanghai Fosun Pharmaceutical Group Co?

Some factors that can influence the equity of Shanghai Fosun Pharmaceutical Group Co include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Shanghai Fosun Pharmaceutical Group Co so important for investors?

The equity of Shanghai Fosun Pharmaceutical Group Co is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Shanghai Fosun Pharmaceutical Group Co influence the company?

The number of employees at Shanghai Fosun Pharmaceutical Group Co can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Shanghai Fosun Pharmaceutical Group Co evolved in recent years?

In recent years, the number of employees at Shanghai Fosun Pharmaceutical Group Co has changed by 0.

How many employees does Shanghai Fosun Pharmaceutical Group Co currently have?

Shanghai Fosun Pharmaceutical Group Co currently has 31,370 undefined employees.

Why is the number of employees important for investors of Shanghai Fosun Pharmaceutical Group Co?

The number of employees is important for investors of Shanghai Fosun Pharmaceutical Group Co as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Shanghai Fosun Pharmaceutical Group Co take to change the number of employees?

To change the number of employees, Shanghai Fosun Pharmaceutical Group Co can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Shanghai Fosun Pharmaceutical Group Co pay?

Over the past 12 months, Shanghai Fosun Pharmaceutical Group Co paid a dividend of 0.42 CNY . This corresponds to a dividend yield of about 1.89 %. For the coming 12 months, Shanghai Fosun Pharmaceutical Group Co is expected to pay a dividend of 0.44 CNY.

What is the dividend yield of Shanghai Fosun Pharmaceutical Group Co?

The current dividend yield of Shanghai Fosun Pharmaceutical Group Co is 1.89 %.

When does Shanghai Fosun Pharmaceutical Group Co pay dividends?

Shanghai Fosun Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of August, July, September, September.

How secure is the dividend of Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co paid dividends every year for the past 23 years.

What is the dividend of Shanghai Fosun Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.44 CNY are expected. This corresponds to a dividend yield of 2 %.

In which sector is Shanghai Fosun Pharmaceutical Group Co located?

Shanghai Fosun Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanghai Fosun Pharmaceutical Group Co from 8/6/2024 amounting to 0.27 CNY, you needed to have the stock in your portfolio before the ex-date on 8/6/2024.

When did Shanghai Fosun Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of Shanghai Fosun Pharmaceutical Group Co in the year 2023?

In the year 2023, Shanghai Fosun Pharmaceutical Group Co distributed 0.56 CNY as dividends.

In which currency does Shanghai Fosun Pharmaceutical Group Co pay out the dividend?

The dividends of Shanghai Fosun Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shanghai Fosun Pharmaceutical Group Co

Our stock analysis for Shanghai Fosun Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Fosun Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.